Peripheral Artery Disease Market Size to Surpass USD 7.74 Billion by 2033 Amid Rising AI Infrastructure Needs

Market Overview:

According to IMARC Group's latest research publication, “Peripheral Artery Disease Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033” The global peripheral artery disease market size was valued at USD 4.89 Billion in 2024. The market is projected to reach USD 7.74 Billion by 2033, exhibiting a CAGR of 4.98% from 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

How AI is Reshaping the Future of Peripheral Artery Disease Market

• AI algorithms analyze complex medical images, like CT and MRI scans, for timely and accurate diagnoses of peripheral artery disease.
• AI-powered predictive analytics forecast disease progression, helping doctors create proactive management strategies and personalized treatment plans for patients.
• AI tools are enhancing precision during interventions by assisting with image guidance and navigation, which improves success rates and patient outcomes.
• Using AI, remote patient monitoring platforms can continuously track a patient’s condition, enabling early intervention and reducing the burden on traditional healthcare settings.
• Natural language processing (NLP) and machine learning models analyze patient data to identify undiagnosed cases, which is crucial for early detection and better care.

Unlock Exclusive Insights: Receive Your Free "Peripheral Artery Disease Market" Sample PDF

Key Trends in the Peripheral Artery Disease Market

• Minimally Invasive Procedures: There's a major shift toward minimally invasive procedures like angioplasty and stenting, which offer patients faster recovery times and fewer complications. Innovations like advanced drug-coated balloons and atherectomy devices are making these interventions even more effective.
• Technological Innovations: The market is buzzing with new technologies, from advanced imaging tools to bioresorbable scaffolds. For example, a recent development saw a company launching a novel intravascular lithotripsy platform designed to modify calcium and cross extremely narrowed vessels in patients.
• Drug-Eluting Technologies: The use of drug-eluting stents and balloons is on the rise. These technologies, which release medication to prevent artery re-narrowing, are gaining traction over older methods due to their improved long-term efficacy and reduced rates of restenosis.
• Focus on Outpatient Care: We're seeing a move away from inpatient hospital stays toward outpatient and ambulatory surgical centers. This is being driven by the demand for cost-effective procedures with shorter recovery times, which advanced, minimally invasive techniques can easily provide.
• Rising Adoption of Bioresorbable Stents: Bioresorbable scaffolds, which dissolve naturally after restoring blood flow, are a key trend. These devices overcome the limitations of permanent implants and are especially beneficial for patients with comorbidities, calcified lesions, or smaller vessel sizes.

Growth Factors in the Peripheral Artery Disease Market

• Growing Geriatric Population: With the number of people aged 65 and above increasing by over 3% in recent times, the demand for PAD treatment is growing. Older adults are naturally at higher risk due to cumulative vascular wear and plaque buildup over time, making them a primary driver for market expansion.
• Rising Prevalence of Diabetes and Obesity: Diabetes significantly increases the risk of PAD, with studies showing patients are 3 to 4 times more likely to develop the condition. With global obesity and diabetes rates on the rise, the patient pool for PAD is continuously expanding, creating a strong demand for diagnostic tools and treatments.
• Technological Advancements: Continuous innovation in medical devices is a huge market driver. The development of advanced endovascular techniques, such as drug-eluting balloons and specialized stents, offers improved outcomes and better patient experiences, encouraging both doctors and patients to adopt these new solutions.
• Increasing Health Awareness and Screening: Public health campaigns and government initiatives are working to improve awareness of PAD symptoms and risk factors. This is leading to earlier detection and intervention, which is crucial for market growth and reducing the disease burden, as evidenced by enhanced reimbursement coverage for PAD-related diagnostics.
• Shift to Minimally Invasive Procedures: Patients and healthcare providers are increasingly favoring less invasive procedures like angioplasty and stent placement over traditional open surgeries. These modern techniques reduce recovery time and lower complication risks, encouraging wider adoption and fueling the demand for advanced interventional devices.

Unlock Exclusive Insights—Buy the Full Report with a Discount!

Leading Companies Operating in the Peripheral Artery Disease Industry:

• Abbott Laboratories
• AngioDynamics
• B. Braun Melsungen AG
• Becton Dickinson and Company
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health Inc.
• Cook Medical LLC
• Koninklijke Philips N.V.
• Medtronic plc
• Terumo Corporation

Peripheral Artery Disease Market Report Segmentation:

By Type:

• Peripheral Angioplasty Balloons
• Peripheral Stents
• Peripheral Catheters
• Inferior Vena Cava (IVC) Filters
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Peripheral Accessories

Peripheral stents represent the largest segment. Peripheral stents are widely used for treating arterial blockages in PAD patients, offering effective vascular support and durability compared to other treatment options.

By End User:

• Hospitals
• Specialty Clinics
• Others

Based on the end-user, the market has been divided into hospitals, specialty clinics, and others.

Regional Insights:

• North America (the United States and Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others)
• Europe (Germany, France, the United Kingdom, Italy, Spain, and others)
• Latin America (Brazil, Mexico, and others)
• Middle East; and Africa.

North America enjoys the leading position due to high healthcare expenditure, advanced medical infrastructure, extensive adoption of innovative PAD treatments, and a growing elderly population prone to PAD-related conditions.

Recent News and Developments in Peripheral Artery Disease Market

• June 2025: A new intravascular lithotripsy (IVL) catheter was launched in the U.S. This novel platform is specifically designed to modify calcium and cross extremely narrowed vessels in PAD patients.
• February 2025: New drug-coated balloon technology, which is activated by light, has been licensed for clinical trials in the U.S. after receiving an experimental device exemption from the FDA.
• August 2024: The FDA published a letter to healthcare providers stating that the previously noted higher mortality risk associated with paclitaxel-coated devices for PAD treatment is no longer substantiated based on a new comprehensive data analysis.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302